NO976112L - 1,6-disubstituerte isokromaner for behandling av migrene - Google Patents
1,6-disubstituerte isokromaner for behandling av migreneInfo
- Publication number
- NO976112L NO976112L NO976112A NO976112A NO976112L NO 976112 L NO976112 L NO 976112L NO 976112 A NO976112 A NO 976112A NO 976112 A NO976112 A NO 976112A NO 976112 L NO976112 L NO 976112L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- isochromes
- disubstituted
- migraine
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74195P | 1995-06-30 | 1995-06-30 | |
| US1123496P | 1996-02-06 | 1996-02-06 | |
| PCT/US1996/008681 WO1997002259A1 (en) | 1995-06-30 | 1996-06-07 | 1,6-disubstituted isochromans for treatment of migraine headaches |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO976112D0 NO976112D0 (no) | 1997-12-29 |
| NO976112L true NO976112L (no) | 1998-03-02 |
Family
ID=26668092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO976112A NO976112L (no) | 1995-06-30 | 1997-12-29 | 1,6-disubstituerte isokromaner for behandling av migrene |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0836599A1 (ja) |
| JP (1) | JPH11509532A (ja) |
| AU (1) | AU6252296A (ja) |
| BR (1) | BR9609631A (ja) |
| CA (1) | CA2225282A1 (ja) |
| CZ (1) | CZ418597A3 (ja) |
| FI (1) | FI974640A0 (ja) |
| MX (1) | MX9710260A (ja) |
| NO (1) | NO976112L (ja) |
| PL (1) | PL324319A1 (ja) |
| SK (1) | SK164297A3 (ja) |
| WO (1) | WO1997002259A1 (ja) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2370270A (en) * | 2000-12-20 | 2002-06-26 | Lilly Co Eli | Pharmaceutical compounds |
| US7335660B2 (en) | 2001-12-19 | 2008-02-26 | Eli Lilly And Company | Isochroman compounds for treatment of CNS disorders |
| GB0130339D0 (en) * | 2001-12-19 | 2002-02-06 | Lilly Co Eli | Isochroman compounds |
| US7110576B2 (en) | 2002-12-30 | 2006-09-19 | Pitney Bowes Inc. | System and method for authenticating a mailpiece sender |
| BRPI0510642A (pt) | 2004-05-05 | 2007-11-20 | Hoffmann La Roche | arilsulfonil benzodioxanos úteis para modulação do receptor de 5-ht6, do receptor de 5ht2a ou ambos |
| WO2006066756A1 (en) | 2004-12-21 | 2006-06-29 | F. Hoffmann-La Roche Ag | Chroman derivatives and uses thereof in the treatment of cns disorders |
| SI1831159T1 (sl) | 2004-12-21 | 2010-04-30 | Hoffmann La Roche | Derivati tetralina in indana ter njune uporabe |
| WO2006066748A1 (en) | 2004-12-21 | 2006-06-29 | F. Hoffmann-La Roche Ag | Tetralin and indane derivatives and uses thereof as 5-ht antagonists |
| DE602005017663D1 (de) | 2004-12-21 | 2009-12-24 | Hoffmann La Roche | Tetralin- und indanderivate und anwendungen davon |
| CA2592001A1 (en) | 2004-12-21 | 2006-06-29 | F. Hoffmann-La Roche Ag | Chroman derivatives and their use as 5-ht receptor ligands |
| BRPI0618206A2 (pt) | 2005-11-03 | 2011-08-23 | Hoffmann La Roche | arilsulfonil cromanos como inibidores de 5-ht6, bem como composição farmacêutica, uso e processo para produção dos mesmos |
| MX2008015843A (es) | 2006-06-20 | 2009-01-09 | Hoffmann La Roche | Derivados de tetralina e indano y usos de los mismos. |
| CA2655524A1 (en) | 2006-06-20 | 2007-12-27 | F. Hoffman-La Roche Ag | Arylsulfonamidyl tetralin derivatives and uses thereof |
| EP2041079A1 (en) | 2006-06-20 | 2009-04-01 | F. Hoffmann-Roche AG | Arylsulfonyl naphthalene derivatives and uses thereof |
| EP2404897A4 (en) * | 2009-03-05 | 2014-02-26 | Sumitomo Chemical Co | PROCESS FOR PREPARING HALOGEN-SUBSTITUTED BENCHENETIMETHANOL |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1552004A (en) * | 1976-05-26 | 1979-09-05 | Takeda Chemical Industries Ltd | Isochroman derivatives |
| ES2133714T3 (es) * | 1993-12-28 | 1999-09-16 | Upjohn Co | Compuestos heterociclicos para el tratamiento de trastornos del snc y cardiovasculares. |
-
1996
- 1996-06-07 CZ CZ974185A patent/CZ418597A3/cs unknown
- 1996-06-07 MX MX9710260A patent/MX9710260A/es unknown
- 1996-06-07 PL PL96324319A patent/PL324319A1/xx unknown
- 1996-06-07 AU AU62522/96A patent/AU6252296A/en not_active Abandoned
- 1996-06-07 BR BR9609631A patent/BR9609631A/pt not_active Application Discontinuation
- 1996-06-07 CA CA002225282A patent/CA2225282A1/en not_active Abandoned
- 1996-06-07 JP JP9505135A patent/JPH11509532A/ja active Pending
- 1996-06-07 WO PCT/US1996/008681 patent/WO1997002259A1/en not_active Application Discontinuation
- 1996-06-07 SK SK1642-97A patent/SK164297A3/sk unknown
- 1996-06-07 EP EP96921264A patent/EP0836599A1/en not_active Withdrawn
-
1997
- 1997-12-29 NO NO976112A patent/NO976112L/no unknown
- 1997-12-30 FI FI974640A patent/FI974640A0/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO976112D0 (no) | 1997-12-29 |
| JPH11509532A (ja) | 1999-08-24 |
| PL324319A1 (en) | 1998-05-25 |
| SK164297A3 (en) | 1998-09-09 |
| CA2225282A1 (en) | 1997-01-23 |
| MX9710260A (es) | 1998-03-29 |
| BR9609631A (pt) | 1999-03-02 |
| CZ418597A3 (cs) | 1998-06-17 |
| FI974640A (fi) | 1997-12-30 |
| WO1997002259A1 (en) | 1997-01-23 |
| AU6252296A (en) | 1997-02-05 |
| FI974640A0 (fi) | 1997-12-30 |
| EP0836599A1 (en) | 1998-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO976112L (no) | 1,6-disubstituerte isokromaner for behandling av migrene | |
| YU64092A (sh) | Fluoralkoksibenzamino derivati heterocikličnih jedinjenja koja sadrže azot | |
| FI941022A0 (fi) | Spirosykliset piperidiinijohdannaiset | |
| FI931370A0 (fi) | Kvaeve innehaollande analoger av icke-aromatiska heterocykliska foereningar med en fusionerad ring | |
| NO955047L (no) | Sekundære aminer som antidiabetiske og antifedme-midler | |
| MX9702865A (es) | Agentes estrogenicos. | |
| ATE263157T1 (de) | Nematizide trifluorbutene | |
| MD1838G2 (ro) | Derivaţi de 5,6-diclorbenzimidazol, procedeu de obţinere a lor, compoziţie farmaceutică şi metodă de tratament sau de prevenire a infecţiei virotice herpetice | |
| DK0772604T3 (da) | Trialzolforbindelser og deres anvendelse som dopamin-D3-ligander | |
| DK0934309T3 (da) | Nye pyridylalkansyreamider som cytostatiske og immunosuppressive midler | |
| ATE202776T1 (de) | Piperinderivate als neurokininantagoniste | |
| DK0737189T3 (da) | Heterocycliske forbindelser til behandling af CNS-forstyrrelser og cardiovaskulære forstyrrelser | |
| ATE242220T1 (de) | Benzimidazolderivate mit dopaminerger wirkung | |
| NO995431D0 (no) | Substituerte 3,3-diamino-2-propennitriler, deres fremstilling og anvendelse | |
| IS6914A (is) | 2-þíó-útskiptar imídasólafleiður og notkun þeirraí lyfjaiðnaðinum | |
| BR0113461A (pt) | Compostos ou sais farmaceuticamente aceitáveis, composições farmacêuticas, método de tratamento de doença ou condição mediada por erab, hadh2 ou (beta)-amilóide em mamìferos, métodos de inibição ou modulação da atividade enzimática de erab ou hadh2 e método de tratamento de mal de alzheimer ou demência em mamìferos | |
| NO970573L (no) | Ylidenforbindelser og deres fremstilling | |
| YU22802A (sh) | Izonipekotamidi za lečenje poremećaja nastalih posredstvom integrina | |
| CO5150221A1 (es) | Nuevas 3-fenoxi- y 3-fenilalquiloxi-2-fenil-propilaminas sustituidas | |
| HUP0001118A2 (hu) | N-szubsztituált pirrolidinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények | |
| DE59406501D1 (de) | Substituierte iminoacetonitrile mit myokardprotektiver wirkung | |
| NO970498L (no) | Benzimidazolderivater med dopaminergisk aktivitet | |
| MX9704733A (es) | Monomeros de ciclohesan-1-ona 4,4-disubstituidos y compuestos relacionados. |